Management Team
Staff
Directors
Advisory Board
Commitment to Global Sustainable Development
Investors
Telum Therapeutics SL is a global leader in drug discovery, leveraging Synthetic Biology and AI-driven Machine Learning to develop cutting-edge antimicrobial solutions. Specializing in the use of Engineered Lytic Proteins, we are pioneering new approaches to combat multidrug-resistant infections with precision and innovation.
Subhendu Basu
PhD, MsC
Chief Executive Officer
https://www.linkedin.com/in/subhendu-basu-ph-d-b627b727
Roberto Díez
PhD, EMBA, MsC
Chief Operating Officer
https://www.linkedin.com/in/robertodiezmartinez/
Diana Gutiérrez
PhD, MsC
Chief Scientific Officer
https://www.linkedin.com/in/diana-guti%C3%A9rrez-fern%C3%A1ndez-2192b6222/
Irene de Miguel
PhD, MsC
Chief Quality Officer
https://www.linkedin.com/in/irene-de-miguel-turullols-b0908b1a1/
Amy B. Fix
MS, MBA
Head of Regulatory
https://www.linkedin.com/in/amy-butscher-fix-04928b/
Verónica Alcolea
PhD
Head of Product Development
https://www.linkedin.com/in/veronica-alcolea-devesa-96766921/
Laura Saludas
PhD
Head of Process and Analytical Development
https://www.linkedin.com/in/laura-saludas-echauri?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base_contact_details%3BxblU55OsSS6RRMFVsaep0g%3D%3D
Guadalupe Hernández
PhD
Senior Scientist – Experimental Biology
https://www.linkedin.com/in/guadalupe-hern%C3%A1ndez-ram%C3%ADrez-788785244/
Cristina Calviño
PhD
Scientist III – Experimental Biology
https://www.linkedin.com/in/cristina-c-66475140/
Weiwei Qiu
MsC
Project Manager
https://www.linkedin.com/in/cristina-c-66475140/
Carmen Monreal
MSc
PhD Candidate
https://www.linkedin.com/in/carmen-monreal-l%C3%B3pez-62257b19a/
María Oneca
MSc
Scientist II – Experimental Biology
https://www.linkedin.com/in/maria-oneca-sola-5a8a0a106/
Elena Cocho
Office Assistant
https://www.linkedin.com/in/elena-cocho-b8795441/
Ana Ayensa
Laboratory Assistant
Jesús M. Hernandez
MD, PhD
Chairman of the board
https://www.linkedin.com/in/jesusmhernandez/
Isabella Santi
Director
https://www.linkedin.com/in/isabella-santi-b3b3b519b/?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base_contact_details%3BEGYS1%2B3kRqmNB5YN2KYSLw%3D%3D
Roberto Díez
PhD, EMBA, MsC
Director
https://www.linkedin.com/in/robertodiezmartinez/
Subhendu Basu
PhD, MsC
Director
https://www.linkedin.com/in/subhendu-basu-ph-d-b627b727
Laura Rodríguez
Director
https://www.linkedin.com/in/laurarodriguezgallego/?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base_contact_details%3BSNujnDRIT4aZRDhyIq0ggg%3D%3D
Albert Ferrer
FCR
Director
https://es.linkedin.com/in/albert-ferrer/
Daniel Couto
Independent Director
hhttps://www.linkedin.com/in/daniel-couto-966bb24/
Prof. Vincent A. Fischetti
President of SAB
https://www.rockefeller.edu/our-scientists/heads-of-laboratories/1160-vincent-a-fischetti/
Alastair Waugh
PhD
SAB Member
https://es.linkedin.com/in/alastair-waugh-5970392b
Willard Dere
MD
SAB Member
https://www.linkedin.com/in/willard-dere-b3bab14/
Rafael Cantón
PhD
SAB Member
https://es.linkedin.com/in/rafael-cant%C3%B3n-48181a30
Emilio Bouza
MD
SAB Member
https://produccioncientifica.ucm.es/investigadores/163507/detalle
César de la Fuente
PhD
SAB Member
https://www.linkedin.com/in/cesardelafuentenunez
Prof. Jerónimo Pachón
MD
SAB Member
https://bibliometria.us.es/prisma/investigador/3125
Chad Euler
PhD, MsC
SAB member
https://www.linkedin.com/in/chad-euler-2393ba21/
Telum Therapeutics SL is an innovative biotechnology company focused on drug discovery, leveraging Synthetic Biology and AI-driven Machine Learning to develop next-generation antimicrobial solutions. Specializing in Engineered Lytic Proteins, Telum is developing new approaches to combat multidrug-resistant infections with precision and innovation.
We support the United Nations’ efforts to advance sustainable development and responsible business practices.
In 2024, Telum Therapeutics joined the UN Global Compact and committed to supporting its Ten Principles in the areas of human rights, labor, environment and anti-corruption.
At Telum, we are aligned with the United Nations 2030 Agenda and contribute to selected Sustainable Development Goals (SDGs) through our research, operations and ESG practices. As part of this effort, our work contributes primarily to:
- SDG 3: Good Health and Well-Being: Developing biological antimicrobial compounds targeting infectious diseases with high unmet medical needs, including multidrug-resistant bacteria.
- SDG 7: Affordable and Clean Energy: Promoting responsible energy use and operational resource efficiency, where applicable.
- SDG 12: Responsible Consumption and Production: Supporting more sustainable laboratory practices, waste reduction, responsible resource use and circularity initiatives.
- SDG 13: Climate Action: Monitoring and reducing our environmental footprint through GHG assessment, laboratory sustainability practices, resource efficiency and waste reduction initiatives.
Telum’s sustainability approach focuses on responsible innovation, ethical conduct, good governance, laboratory sustainability and continuous improvement as the company grows.
Telum Therapeutics is a participant of the United Nations Global Compact. Participation does not imply endorsement or certification by the United Nations.
Shared Impact — Recognitions and Initiatives
My Green Lab Certification (Gold, 2025)
In September 2025, Telum Therapeutics Lab was awarded the Gold Level My Green Lab Certification, the global standard for laboratory sustainability. This recognition reinforces our commitment to real action on sustainability, reducing our environmental footprint, and embedding sustainable practices into our scientific research.
Our certification complements our CSR strategy and supports several United Nations Sustainable Development Goals, particularly:
- SDG 7: Affordable and Clean Energy: Ensure access to affordable, reliable, sustainable and modern energy.
- SDG 12: Responsible Consumption and Production: Ensure sustainable consumption and production patterns.
- SDG 13: Climate Action: Take urgent action to combat climate change and its impacts.

Treedom Partnership
We are planting trees in conjunction with Treedom.
Our Corporate Social Responsibility project with Treedom aims to have a positive impact on the environment and the economy, aligning with 10 of the 17 Sustainable Development Goals (SDGs). Through this partnership, Telum supports reforestation in multiple countries and collaborates with local NGOs, contributing to the preservation of biodiversity and the fight against climate change.
This initiative also provides economic benefits to local communities by promoting sustainable agriculture, job creation, and income generation. By empowering local farmers, the project alleviates poverty and fosters inclusive economic growth.
Get to know our forest: https://www.treedom.net/en/organization/telum-therapeutics-6526/event/telum-therapeutics-global-forest
Our Ongoing Commitment
At Telum Therapeutics, sustainability is not an accessory, it is integral to our mission. By combining pioneering scientific innovation with a strong responsibility to people and the planet, we contribute to a healthier world and a more sustainable future.
